Does Dr. MITCHELL CAIRO have financial conflicts of interest?

Dr. MITCHELL CAIRO (MD) has received a total of $886,669 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $861,316 in personal promotional payouts (consulting, meals, travel) and $25,353 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MITCHELL CAIRO?

According to CMS Open Payments data, Dr. MITCHELL CAIRO received funding from JAZZ PHARMACEUTICALS ($286,440), SERVIER PHARMACEUTICALS ($157,686), and KITE PHARMA ($125,357).

Does Dr. MITCHELL CAIRO receive research grants or speaking fees?

Dr. MITCHELL CAIRO has received $861,316 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $25,353 in clinical research grants.

DR. MITCHELL CAIRO

MDReal-Time Hydrated

Specialty: Pediatrics, Pediatric Hematology-Oncology

Practice Location: HAWTHORNE, NY 10532

NPI Number: 1669446399

LIFETIME INDUSTRY VALUE

$886,669

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. CAIRO is a verified Pediatrics, Pediatric Hematology-Oncology practitioner based in HAWTHORNE, NY.

Between 2021 and 2025, Dr. CAIRO had an overall industry promotional and research financial footprint of $886,669 as recorded in the federal CMS Open Payments database.

$861,316 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$25,353 was allocated to sponsored clinical trials and medical research activities.

Dr. CAIRO's primary funding source is JAZZ PHARMACEUTICALS, which accounts for $286,440 (representing 32.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JAZZ PHARMACEUTICALS

Rank 1

$286,440

32.3%

SERVIER PHARMACEUTICALS

Rank 2

$157,686

17.8%

KITE PHARMA

Rank 3

$125,357

14.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.